Albi score predicts overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT)
La radiologia medica · 2024
DOI: 10.1007/s11547-024-01943-3 ↗Kurz gefasst
Fachartikel in der Zeitschrift La radiologia medica, 2024. Verfasst von Monica Finessi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Nuclear Medicine Unit, A.O.U. Città Della Salute e della Scienza Di Torino, University of Turin, Turin, Italy. mfinessi@cittadellasalute.to.it. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Bilirubin, Serum Albumin. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: We aimed to evaluate the prognostic impact of baseline clinical features and treatment procedure, including liver function measured with albumin-bilirubin (ALBI) formula and dosing methods in HCC patients treated with SIRT. MATERIAL AND METHODS: The study includes 82 consecutive patients with liver-dominant HCC treated with SIRT (90Y glass microspheres, TheraSphereTM) between October 2014 and September 2023. Twenty-five patients were treated with standard dosimetry, while for remaining patients, multi-compartment dosimetry was performed using Simplicit90YTM software. Impact of baseline patient's characteristics including presence of portal vein thrombosis (PVT), Child-Pugh score (CP), ALBI score, bilirubin levels, tumor size and prior locoregional liver-directed or systemic treatments was assessed through multivariable Cox proportional hazard model. RESULTS: Median follow-up after treatment was 40.0 months (15.2-67.9). At univariable analysis, ALBI score and bilirubin levels were found to be independent prognostic factors for survival after SIRT (p = 0.001, respectively); furthermore, at Cox proportional hazards analysis, HR for death of ALBI 2 versus ALBI 1 was 10.54 (95% CI, 1.42-78.19, p = 0.021), while despite not significant, HR in patients with bilirubin levels over 1.1 mg/dl was 2.67 (0.75-9.44, p = 0.118). Conversely, no significant association was found between OS and cirrhosis, tumor size and PVT. CONCLUSION: ALBI score demonstrated to impact OS in HCC patients treated with SIRT thus going beyond a simple prediction of treatment-related toxicity. The present results are relevant for the selection of HCC patients for SIRT in a real-world clinical setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Nuclear Medicine Unit, A.O.U. Città Della Salute e della Scienza Di Torino, University of Turin, Turin, Italy. mfinessi@cittadellasalute.to.it.
- Nuclear Medicine Unit, A.O.U. Città Della Salute e della Scienza Di Torino, University of Turin, Turin, Italy.
- Interventional Radiology Unit, Department of Diagnostic Imaging and Interventional Radiology, A.O.U. Città Della Salute e della Scienza Di Torino, Turin, Italy.
- Gastroenterology and Digestive Endoscopy Unit, AOU Città Della Salute e della Scienza, University of Turin, Turin, Italy.
- General Surgery 2U-Liver Transplant Unit, A.O.U. Città Della Salute e della Scienza Di Torino, University of Turin, Turin, Italy.
- Department of Surgical Sciences, University of Torino, Turin, Italy.
Zitieren
APA
Finessi, M., Cioffi, M., Grimaldi, S., Fronda, M., Rovera, G., Passera, R., Carucci, P., Gaia, S., Rolle, E., Rizza, G., Colli, F., Saracco, G. M., Romagnoli, R., Calandri, M., Fonio, P., Morbelli, S. D., & Doriguzzi Breatta, A. (2024). Albi score predicts overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT). La radiologia medica. https://doi.org/10.1007/s11547-024-01943-3
Vancouver
Finessi M, Cioffi M, Grimaldi S, Fronda M, Rovera G, Passera R, et al. Albi score predicts overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT). La radiologia medica. 2024. doi:10.1007/s11547-024-01943-3
BibTeX
@article{Finessi2024,
author = {Finessi, Monica and Cioffi, Martina and Grimaldi, Serena and Fronda, Marco and Rovera, Guido and Passera, Roberto and Carucci, Patrizia and Gaia, Silvia and Rolle, Emanuela and Rizza, Giorgia and Colli, Fabio and Saracco, Giorgio Maria and Romagnoli, Renato and Calandri, Marco and Fonio, Paolo and Morbelli, Silvia Daniela and Doriguzzi Breatta, Andrea},
title = {Albi score predicts overall survival (OS) in patients with hepatocellular carcinoma (HCC) treated with selective internal radiation therapy (SIRT)},
journal = {La radiologia medica},
year = {2024},
doi = {10.1007/s11547-024-01943-3}
}
EUVIMED